[1]
H. Malik, M. Hudaib, and A. Rehman, “Vorasidenib- A Paradigm Shift in IDH1- or IDH2-Mutant Low-Grade Glioma Treatment”, J Pak Med Assoc, vol. 74, no. 10, pp. 1912–1913, Sep. 2024.